2019年10月13日(日) 12:30 〜 13:30 第1会場 (メインホール)

Chairs：Chan Hyung KIM（Vice-president, AsCNP/ Department of Psychiatry, Yonsei University College of Medicine, Korea）、池田　和隆（第6回アジア神経精神薬理学会会長 / President, AsCNP / 東京都医学総合研究所精神行動医学研究分野）

※講演言語：英語

In Asia, a substantial number of patients suffer from neuropsychiatric disorders, and the prevalence of mental health problems, such as schizophrenia, depression, suicide, alcohol and substance abuse, and dementia, is rapidly increasing. To implement measures against these disorders, the Asian College of Neuropsychopharmacology (AsCNP) was founded in 2008. The mission of AsCNP is to encourage research, facilitate the communication of ideas in convergent disciplines of neuropsychopharmacology in Asia, develop new pharmacotherapies for the treatment for psychiatric and neurological disorders, provide education and training opportunities, and empower patients and their families with professional knowledge. AsCNP has society-based and individual-based membership systems. Currently, AsCNP has 9 affiliated societies/sections and more than 50 individual members in 16 countries/regions. Therefore, AsCNP has more than 3200 members (2900 ordinary members and 300 honorary members/student members). The AsCNP congress is regularly held every 2 years. There are two Associate Journals, “Clinical Psychopharmacology and Neuroscience” and “Neuropsychopharmacology Reports.” These current status of AsCNP will be introduced by Prof. Atsumi Nitta, the AsCNP Secretary General. Prof. Chay Hoon Tan, the AsCNP President-elect, will introduce 7th AsCNP Biennial Congress in Singapore in 2021. Prof. Shih-Ku Lin, an AsCNP Vice President, will explain Award Committee as the committee chair. The AsCNP Lundbeck Science Award was launched this year and will continue. Prof. Andi J. Tanra, the AsCNP Past-President Chair of Education Committee, will talk about 1st ASEAN-AsCNP International Neuropsychopharmacology Congress in Yogyakarta, Indonesia in 2019 and 2nd one in the future. Prof. Winston Shen, an AsCNP Advisor, and Prof. Naotaka Shinfuku, the Founding President of Asian Federation of Psychiatric Associations (AFPA), will introduce AFPA and an example of Asian collaborations, the REAP (Research Antipsychotic Prescriptions) study. Prof. Kazutaka Ikeda, the AsCNP President, will talk about related neuropsychopharmacology societies. Collegium Internationale Neuro-Psychopharmacologicum (CINP) is an important partner of AsCNP. The CINP World Congress will be held in Taipei on June 25-28, 2020, and in Tokyo on May 25-28, 2024. American College of Neuropsychopharmacology (ACNP) is also a leader society in neuropsychopharmacology. ACNP provides AsCNP 6-8 slots to participate in their Annual Meeting every year.
AsCNP welcomes neuropsychopharmacologists, psychiatrists, and neurologists, as either individual or society members, in Asia and other regions to join AsCNP and engage in its activities.</rec>